Related Experiment Video
Updated: Dec 17, 2025

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
Published on: February 14, 2025
Hypoxic tumor microenvironment: Implications for cancer therapy
Sukanya Roy1, Subhashree Kumaravel1, Ankith Sharma1
1Department of Medical Physiology, Texas A&M Health Science Center, College of Medicine, Bryan, TX 77807, USA.
Impact Statement:
Hypoxia contributes to tumor aggressiveness and promotes growth of many solid tumors that are often resistant to conventional therapies. In order to achieve successful therapeutic strategies targeting different cancer types, it is necessary to understand the molecular mechanisms and signaling pathways that are induced by hypoxia. Aberrant tumor vasculature and alterations in cellular metabolism and drug resistance due to hypoxia further confound this problem. This review focuses on the implications of hypoxia in an inflammatory TME and its impact on the signaling and metabolic pathways regulating growth and progression of cancer, along with changes in lymphangiogenic and angiogenic mechanisms. Finally, the overarching role of hypoxia in mediating therapeutic resistance in cancers is discussed.
Insights
Hypoxia, or low oxygen, fuels tumor growth and resistance to cancer treatments. Understanding hypoxia
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Hypoxia is a critical factor in solid tumor progression.
- It drives tumor aggressiveness and resistance to therapies.
- Tumor hypoxia complicates treatment by altering metabolism and vasculature.
Purpose of the Study:
- To review the role of hypoxia in the tumor microenvironment (TME).
- To examine hypoxia-induced signaling and metabolic pathways in cancer.
- To discuss hypoxia's impact on angiogenesis, lymphangiogenesis, and therapeutic resistance.
Main Methods:
- Literature review of studies on hypoxia in cancer.
- Analysis of molecular mechanisms and signaling pathways.
- Synthesis of data on metabolic and vascular changes.
Main Results:
- Hypoxia significantly impacts cancer cell signaling and metabolism.
- It promotes aberrant tumor vasculature, including angiogenesis and lymphangiogenesis.
- Hypoxia is a key mediator of resistance to cancer therapies.
Conclusions:
- Targeting hypoxia-induced pathways is crucial for effective cancer treatment.
- A deeper understanding of hypoxia's role in the TME is needed.
- Addressing hypoxia may overcome therapeutic resistance in various cancers.
More Related Videos
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Immunotherapy
Regulation of Angiogenesis and Blood Supply
Targeted Cancer Therapies
There are several types of targeted therapies against...

